Effect of MP‐AzeFlu compared to monotherapy on COX‐2, PGE2, and EP2 gene expression in upper airway mucosa

MP‐AzeFlu (intranasal fluticasone and azelastine) has been widely studied and has demonstrated efficacy in Allergic rhinitis with a superior effect compared to these drugs administered individually; however, the mechanism by which MP‐AzeFlu produces this improved clinical effect has not yet been fully explained. In this study, we investigated the effect of MP‐AzeFlu and fluticasone propionate (FP) on arachidonic acid metabolism as measured by changes in regulation of cyclooxygenase (COX) isoforms, prostaglandin (PG) D2, PGE2, PGE2 receptor (EP) 2, and EP3. Expression of these key inflammation markers was assessed through an in vitro model of upper airway inflammation using fibroblasts derived from both healthy and inflamed upper airway mucosa. Both MP‐AzeFlu and FP inhibited interleukin‐1β‐induced COX‐2 messenger RNA (mRNA) and protein expression and PGE2 secretion in vitro. MP‐AzeFlu and FP both upregulated EP2 mRNA expression, though neither upregulated EP2 protein expression. This downregulation of COX‐2 and PGE2 coupled with upregulation of EP2 receptor expression reinforces the anti‐inflammatory effect of MP‐AzeFlu in upper airway inflammation.

[1]  W. Zou,et al.  A comprehensive gene expression profile of allergic rhinitis-derived nasal fibroblasts and the potential mechanism for its phenotype , 2022, Human & experimental toxicology.

[2]  A. Peters,et al.  Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches , 2021, Allergy.

[3]  J. Bousquet,et al.  MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review , 2021, International Archives of Allergy and Immunology.

[4]  A. Peters,et al.  Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches , 2021, Allergy.

[5]  Shengwen Shao,et al.  Interleukin-17A up-regulates thymic stromal lymphopoietin production by nasal fibroblasts from patients with allergic rhinitis , 2020, European Archives of Oto-Rhino-Laryngology.

[6]  A. Peters,et al.  Utilizing Endotypes, Phenotypes, and Inflammatory Markers to Guide Treatment Decisions in Chronic Rhinosinusitis. , 2020, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[7]  Byung Guk Kim,et al.  Effect of fluticasone propionate on human nasal fibroblasts exposed to urban particulate matter. , 2019, Auris, nasus, larynx.

[8]  P. Hellings,et al.  MP29‐02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite‐allergic rhinitis , 2018, Allergy.

[9]  S. Durham,et al.  Pathogenesis of rhinitis , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  J. Wilson,et al.  The Role of the Fibroblast in Inflammatory Upper Airway Conditions. , 2016, The American journal of pathology.

[11]  J. Bousquet,et al.  A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. , 2012, The Journal of allergy and clinical immunology.

[12]  J. Mullol,et al.  Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma. , 2011, The Journal of allergy and clinical immunology.

[13]  F. Hampel,et al.  Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[14]  Degeng Wang,et al.  Discrepancy between mRNA and protein abundance: Insight from information retrieval process in computers , 2008, Comput. Biol. Chem..

[15]  J. Mullol,et al.  Low E-prostanoid 2 receptor levels and deficient induction of the IL-1β/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated respiratory disease. , 2016, The Journal of allergy and clinical immunology.

[16]  I. Um,et al.  Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system , 2015, Scientific Reports.